Literature DB >> 3715416

Prediction of long-term outcome in schizophrenia by prognostic scales.

H J Möller, W Schmid-Bode, D von Zerssen.   

Abstract

The predictive validity of four prognostic scales described in the literature (Gittelman-Klein Scale, Goldstein Scale, Phillips Scale, Strauss-Carpenter Scale) and of four newly developed prognostic scores was tested in two long-term followup studies on schizophrenic patients. Among the prognostic scales of the literature, the Strauss-Carpenter Scale showed the best results; it reached a level that was attained by only three of the newly developed scales. The three other scales of the literature could also prove their predictive validity. It may be concluded from the results that a scale has a comparatively high predictive value when certain dimensions and aspects are considered but that a certain maximum cannot, in general, be exceeded--even if more items are added to the prognostic scale. A higher number of items may be able to guarantee a better stability of predictive power in different samples.

Entities:  

Mesh:

Year:  1986        PMID: 3715416     DOI: 10.1093/schbul/12.2.225

Source DB:  PubMed          Journal:  Schizophr Bull        ISSN: 0586-7614            Impact factor:   9.306


  3 in total

1.  The Prognostic Scale by Strauss and Carpenter and its validity.

Authors:  M Händel; J Bailer; W Bräuer; D Laubenstein; E R Rey
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1996       Impact factor: 5.270

2.  The Munich 15-year follow-up study (MUFUSSAD) on first-hospitalized patients with schizophrenic or affective disorders: comparison of psychopathological and psychosocial course and outcome and prediction of chronicity.

Authors:  Hans-Jürgen Möller; Markus Jäger; Michael Riedel; Michael Obermeier; Anton Strauss; Ronald Bottlender
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2010-05-22       Impact factor: 5.270

Review 3.  Systematic of psychiatric disorders between categorical and dimensional approaches: Kraepelin's dichotomy and beyond.

Authors:  Hans-Jürgen Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-06       Impact factor: 5.270

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.